CRINETICS Insider Sale: Okey Stephanie Sells 6,900 Shares Near $35.70
CRINETICS insider sale: Okey Stephanie sells 6,900 shares, a routine 53% divestment at ~$35.60—no crash, just portfolio rebalancing. Watch future clinical wins and investor flow.
- CRINETICS PHARMACEUTICALS IN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read